Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Stopped Study has been temporarily stopped until another study is completed. Data from the other study may inform changes to this study.

Conditions

• Medium-chain Acyl-CoA Dehydrogenase Deficiency

Interventions

• DRUG: Triheptanoin

Sponsor

Jerry Vockley, MD, PhD

Collaborators

• [object Object]